MENU
GENW
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

GENW stock forecast, quote, news & analysis

The investment seeks current income and long-term capital appreciation... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for GENW with price predictions
Nov 10, 2026

GENW in downward trend: price may drop because broke its higher Bollinger Band on November 05, 2026

GENW broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 16 similar instances where the stock broke above the upper band. In 13 of the 16 cases the stock fell afterwards. This puts the odds of success at 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 12 of 27 cases where GENW's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 44%.

The Aroon Indicator for GENW entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GENW's RSI Indicator exited the oversold zone, 6 of 6 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on GENW as a result. In 19 of 21 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

The Moving Average Convergence Divergence (MACD) for GENW just turned positive on October 16, 2026. Looking at past instances where GENW's MACD turned positive, the stock continued to rise in 17 of 19 cases over the following month. The odds of a continued upward trend are 89%.

Following a +1.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where GENW advanced for three days, in 48 of 60 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are BP plc (NYSE:BP), Barclays PLC (NYSE:BCS), Ericsson (NASDAQ:ERIC).

Industry description

The investment seeks current income and long-term capital appreciation. Under normal market conditions, the fund will invest at least 80% of its assets plus borrowings for investment purposes in foreign equity securities that have records of paying dividends. In addition, the fund will invest in a diversified portfolio of 25 to 50 securities typically spread across many economic sectors.

Market Cap

The average market capitalization across the Genter Capital International Dividend ETF (GENW) ETF is 113.05B. The market cap for tickers in the group ranges from 27.53B to 236.03B. MUFG holds the highest valuation in this group at 236.03B. The lowest valued company is NMR at 27.53B.

High and low price notable news

The average weekly price growth across all stocks in the Genter Capital International Dividend ETF (GENW) ETF was -1%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was -0%. BBVA experienced the highest price growth at 10%, while BP experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Genter Capital International Dividend ETF (GENW) ETF was 12%. For the same stocks of the ETF, the average monthly volume growth was 19% and the average quarterly volume growth was -16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 49
P/E Growth Rating: 61
Price Growth Rating: 46
SMR Rating: 54
Profit Risk Rating: 29
Seasonality Score: 12 (-100 ... +100)
GENW in downward trend: price may drop because broke its higher Bollinger Band on November 05, 2026